Technical Analysis for AREC - Arecor Therapeutics PLC
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 128.50 | 0.00% | 0.00 |
AREC closed unchanged on Friday, April 19, 2024, on 17 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Apr 22
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% | |
| Lower Bollinger Band Touch | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Hammer Candlestick | Bullish | 0.00% | |
| Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
| Volume Surge | Other | 0.00% | |
| Doji - Bullish? | Reversal | 0.00% | |
| Lower Bollinger Band Walk | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Down 1% | 1 day ago |
| Lizard Bullish Entry | 1 day ago |
| Hammer Candlestick Entry | 1 day ago |
| Rose Above Previous Day's High | 1 day ago |
| Rose Above Lower Bollinger Band | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Arecor Therapeutics PLC, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products. It is developing AT247, an ultra-rapid acting insulin for patients with Type I and Type II diabetics; and AT278, an ultra-concentrated rapid acting insulin formulation that has been designed to accelerate the absorption of insulin post injection. The company was founded in 2007 and is headquartered in Little Chesterford, the United Kingdom.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Branches Of Biology Biopharmaceutical Clinical Medicine Pharmacy Pharmaceutical Industry Diabetes Therapeutic Products Peptide Hormones Recombinant Proteins
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Branches Of Biology Biopharmaceutical Clinical Medicine Pharmacy Pharmaceutical Industry Diabetes Therapeutic Products Peptide Hormones Recombinant Proteins
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 280.0 |
| 52 Week Low | 125.0 |
| Average Volume | 19,366 |
| 200-Day Moving Average | 176.07 |
| 50-Day Moving Average | 142.14 |
| 20-Day Moving Average | 138.18 |
| 10-Day Moving Average | 135.05 |
| Average True Range | 5.11 |
| RSI (14) | 29.08 |
| ADX | 18.38 |
| +DI | 17.26 |
| -DI | 29.15 |
| Chandelier Exit (Long, 3 ATRs) | 134.67 |
| Chandelier Exit (Short, 3 ATRs) | 140.33 |
| Upper Bollinger Bands | 149.14 |
| Lower Bollinger Band | 127.21 |
| Percent B (%b) | 0.06 |
| BandWidth | 15.88 |
| MACD Line | -3.82 |
| MACD Signal Line | -2.60 |
| MACD Histogram | -1.2176 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 133.00 | ||||
| Resistance 3 (R3) | 133.00 | 131.50 | 132.25 | ||
| Resistance 2 (R2) | 131.50 | 130.35 | 131.50 | 132.00 | |
| Resistance 1 (R1) | 130.00 | 129.65 | 130.00 | 130.00 | 131.75 |
| Pivot Point | 128.50 | 128.50 | 128.50 | 128.50 | 128.50 |
| Support 1 (S1) | 127.00 | 127.35 | 127.00 | 127.00 | 125.25 |
| Support 2 (S2) | 125.50 | 126.65 | 125.50 | 125.00 | |
| Support 3 (S3) | 124.00 | 125.50 | 124.75 | ||
| Support 4 (S4) | 124.00 |
